First experience with prostate artery embolization for benign prostatic hyperplasia

Prostatic arterial embolisation for men with benign prostatic hyperplasia: a Cochrane review

“…Six studies (six records) are ongoing [32][33][34][35][36][37]. We included a total of nine studies (seven RCTs: 21 records; two NRSs: six records) in the review [38][39][40][41][42][43][44][45][46]. The flow of literature through the assessment process is shown in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart (Fig.…”

“…Four studies were supported by device manufacturers, government, or medical society [38,41,42,44]. One study reported no external funding [39], and the others did not report the funding source [40,43,45,46]. Study authors of five included studies reported that they had no relevant conflicts of interest [38][39][40]42,43].…”

“…The mean age, prostate volume, and IPSS were 67 years, 87.1 mL, and 21.4, respectively. The PAE procedures were conducted via a femoral approach under local anaesthesia, while two NRSs did not report its PAE technique [44,45]. Eight studies [38][39][40][41][43][44][45][46] used TURP as a comparator and one study [42] compared PAE to sham.…”

“…The PAE procedures were conducted via a femoral approach under local anaesthesia, while two NRSs did not report its PAE technique [44,45]. Eight studies [38][39][40][41][43][44][45][46] used TURP as a comparator and one study [42] compared PAE to sham. No study compared PAE to laser ablation or enucleation of the prostate, or other minimally invasive therapies.…”

“…Study authors of five included studies reported that they had no relevant conflicts of interest [38][39][40]42,43]. Two studies reported conflicts of interest of members of the investigative team with the device manufacturer [41,44], and the other studies did not report the conflicts of interest [45,46].…”